These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25562712)

  • 1. Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome.
    Freriks K; Verhaak CM; Sas TC; Menke LA; Wit JM; Otten BJ; de Muinck Keizer-Schrama SM; Smeets DF; Netea-Maier RT; Hermus AR; Kessels RP; Timmers HJ
    Horm Behav; 2015 Mar; 69():59-67. PubMed ID: 25562712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
    Freriks K; Sas TC; Traas MA; Netea-Maier RT; den Heijer M; Hermus AR; Wit JM; van Alfen-van der Velden JA; Otten BJ; de Muinck Keizer-Schrama SM; Gotthardt M; Dejonckere PH; Zandwijken GR; Menke LA; Timmers HJ
    Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Zandwijken GR; de Ridder MA; Stijnen T; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):212-9. PubMed ID: 20105186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment.
    Verver EJ; Freriks K; Sas TC; Huygen PL; Pennings RJ; Smeets DF; Hermus AR; Menke LA; Wit JM; Otten BJ; van Alfen-van der Velden JA; de Muinck Keizer-Schrama SM; Topsakal V; Admiraal RJ; Timmers HJ; Kunst HP
    Otol Neurotol; 2014 Oct; 35(9):1577-84. PubMed ID: 25133471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.
    Perry RJ; Gault EJ; Paterson WF; Dunger DB; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):298-308. PubMed ID: 24751470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome.
    van Pareren YK; Duivenvoorden HJ; Slijper FM; Koot HM; Drop SL; de Muinck Keizer-Schrama SM
    Horm Res; 2005; 63(5):238-44. PubMed ID: 15900109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    Horm Res Paediatr; 2011 Feb; 75(2):115-22. PubMed ID: 20814189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-responsive aspects of cognition in girls with Turner syndrome.
    Ross JL; Roeltgen D; Stefanatos GA; Feuillan P; Kushner H; Bondy C; Cutler GB
    J Clin Endocrinol Metab; 2003 Jan; 88(1):292-6. PubMed ID: 12519868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.
    Sas TC; Gault EJ; Bardsley MZ; Menke LA; Freriks K; Perry RJ; Otten BJ; de Muinck Keizer-Schrama SM; Timmers H; Wit JM; Ross JL; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):289-97. PubMed ID: 24776783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of growth hormone therapy in Turner syndrome.
    Bramswig JH
    Endocrine; 2001 Jun; 15(1):5-13. PubMed ID: 11572325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone.
    Taback SP; Van Vliet G
    BMC Pediatr; 2011 May; 11():49. PubMed ID: 21619701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.
    Rosenfeld RG; Attie KM; Frane J; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM; Mahoney CP; Moore WV; Saenger P; Johanson AJ
    J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities.
    Rudman D; Goldsmith M; Kutner M; Blackston D
    J Pediatr; 1980 Jan; 96(1):132-5. PubMed ID: 7350294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of growth hormone effects on cognitive function in girls with Turner syndrome.
    Ross JL; Feuillan P; Kushner H; Roeltgen D; Cutler GB
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1814-7. PubMed ID: 9177388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.